Company Filing History:
Years Active: 2015-2016
Title: Megan R Carpenter: Innovator in Antimicrobial Bacteria Strains
Introduction
Megan R Carpenter is a prominent inventor based in Wilmington, DE (US). She has made significant contributions to the field of microbiology, particularly in the development of antimicrobial agents. With a total of 2 patents, her work is paving the way for innovative solutions in combating bacterial infections.
Latest Patents
Megan's latest patents focus on novel antimicrobial bacteria strains and their uses. The first patent provides innovative antimicrobial bacteria strains and outlines their applications in preparing new antimicrobial agents. Additionally, the second patent reiterates the same groundbreaking concept, emphasizing the importance of these novel antimicrobial agents in various applications.
Career Highlights
Megan R Carpenter is currently employed at Fraunhofer USA, Inc., where she continues her research and development in the field of antimicrobial solutions. Her work is instrumental in advancing the understanding and application of antimicrobial bacteria in various industries.
Collaborations
Megan collaborates with esteemed colleagues, including Zusheng Li and Vadim Mett, who contribute to her research endeavors. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Megan R Carpenter is a trailblazer in the field of antimicrobial research, with her patents reflecting her commitment to innovation. Her work at Fraunhofer USA, Inc. and collaborations with fellow researchers underscore her significant impact on the industry.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.